APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Detection and Analysis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Detection and Analysis Market Outlook and Growth Opportunities 2026

Report ID 174123100422 January 2026217 pages

Choose your research edition.

Industry ResearchDrug Detection and Analysis Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Detection and Analysis Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Drug Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Detection and Analysis Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Detection and Analysis Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Drug Detection and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Detection and Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Detection and Analysis market include Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA and Medpace, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Detection and Analysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Detection and Analysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Detection and Analysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Detection and Analysis market.

Drug Detection and Analysis Segment by Company

Eurofins Scientific

SGS

Labcorp

Intertek

WuXi AppTec

Charles River Laboratories

ICON pIc

IQVIA

Medpace

Syneos Health

Frontage Laboratories

Pace Analytical Services

Element Materials Technology

ALS Limited

STERIS

LGC Limited

Almac Group

Catalent

Cambrex

Alcami

Toxikon

Boston Analytical

Drug Detection and Analysis Segment by Type

Chemical Drug Testing

Biopharmaceutical Testing

Traditional Chinese Medicine Testing

Others

Drug Detection and Analysis Segment by Application

Pharmaceutical Companies

Biopharmaceutical Companies

Drug Regulatory Authorities

Others

Drug Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Detection and Analysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Detection and Analysis key companies, revenue, market share, and recent developments.

3. To split the Drug Detection and Analysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Detection and Analysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Detection and Analysis significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Detection and Analysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Detection and Analysis industry.

Chapter 3: Detailed analysis of Drug Detection and Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Detection and Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Detection and Analysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Detection and Analysis Industry Trends Table 2. Drug Detection and Analysis Industry Drivers Table 3. Drug Detection and Analysis Industry Opportunities and Challenges Table 4. Drug Detection and Analysis Industry Restraints Table 5. Global Drug Detection and Analysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Detection and Analysis Revenue Share by Company (2021-2026) Table 7. Global Drug Detection and Analysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Detection and Analysis Key Company Manufacturing Base & Headquarters Table 9. Global Drug Detection and Analysis Company, Product Type & Application Table 10. Global Drug Detection and Analysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Detection and Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chemical Drug Testing Table 15. Significant Companies of Biopharmaceutical Testing Table 16. Significant Companies of Traditional Chinese Medicine Testing Table 17. Significant Companies of Others Table 18. Global Drug Detection and Analysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Drug Detection and Analysis Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Drug Detection and Analysis Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Drug Detection and Analysis Sales Value Share by Type (2021-2026) Table 22. Global Drug Detection and Analysis Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Companies Table 24. Significant Companies of Biopharmaceutical Companies Table 25. Significant Companies of Drug Regulatory Authorities Table 26. Significant Companies of Others Table 27. Global Drug Detection and Analysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Detection and Analysis Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Drug Detection and Analysis Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Drug Detection and Analysis Sales Value Share by Application (2021-2026) Table 31. Global Drug Detection and Analysis Sales Value Share by Application (2027-2032) Table 32. Global Drug Detection and Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Detection and Analysis Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Drug Detection and Analysis Sales Value Share by Region (2021-2026) Table 35. Global Drug Detection and Analysis Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Drug Detection and Analysis Sales Value Share by Region (2027-2032) Table 37. Global Drug Detection and Analysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Drug Detection and Analysis Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Drug Detection and Analysis Sales Value Market Share by Country (2021-2026) Table 40. Global Drug Detection and Analysis Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Drug Detection and Analysis Sales Value Market Share by Country (2027-2032) Table 42. Eurofins Scientific Company Information Table 43. Eurofins Scientific Business Overview Table 44. Eurofins Scientific Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eurofins Scientific Drug Detection and Analysis Product Portfolio Table 46. Eurofins Scientific Recent Development Table 47. SGS Company Information Table 48. SGS Business Overview Table 49. SGS Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. SGS Drug Detection and Analysis Product Portfolio Table 51. SGS Recent Development Table 52. Labcorp Company Information Table 53. Labcorp Business Overview Table 54. Labcorp Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Labcorp Drug Detection and Analysis Product Portfolio Table 56. Labcorp Recent Development Table 57. Intertek Company Information Table 58. Intertek Business Overview Table 59. Intertek Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Intertek Drug Detection and Analysis Product Portfolio Table 61. Intertek Recent Development Table 62. WuXi AppTec Company Information Table 63. WuXi AppTec Business Overview Table 64. WuXi AppTec Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. WuXi AppTec Drug Detection and Analysis Product Portfolio Table 66. WuXi AppTec Recent Development Table 67. Charles River Laboratories Company Information Table 68. Charles River Laboratories Business Overview Table 69. Charles River Laboratories Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Charles River Laboratories Drug Detection and Analysis Product Portfolio Table 71. Charles River Laboratories Recent Development Table 72. ICON pIc Company Information Table 73. ICON pIc Business Overview Table 74. ICON pIc Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. ICON pIc Drug Detection and Analysis Product Portfolio Table 76. ICON pIc Recent Development Table 77. IQVIA Company Information Table 78. IQVIA Business Overview Table 79. IQVIA Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. IQVIA Drug Detection and Analysis Product Portfolio Table 81. IQVIA Recent Development Table 82. Medpace Company Information Table 83. Medpace Business Overview Table 84. Medpace Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Medpace Drug Detection and Analysis Product Portfolio Table 86. Medpace Recent Development Table 87. Syneos Health Company Information Table 88. Syneos Health Business Overview Table 89. Syneos Health Drug Detection and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Syneos Health Drug Detection and Analysis Product Portfolio Table 91. Syneos Health Recent Development Table 92. Frontage Laboratories Company Information Table 93. Frontage Laboratories Business Overview Table 94. Frontage Laboratories Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Frontage Laboratories Drug Detection and Analysis Product Portfolio Table 96. Frontage Laboratories Recent Development Table 97. Pace Analytical Services Company Information Table 98. Pace Analytical Services Business Overview Table 99. Pace Analytical Services Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Pace Analytical Services Drug Detection and Analysis Product Portfolio Table 101. Pace Analytical Services Recent Development Table 102. Element Materials Technology Company Information Table 103. Element Materials Technology Business Overview Table 104. Element Materials Technology Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Element Materials Technology Drug Detection and Analysis Product Portfolio Table 106. Element Materials Technology Recent Development Table 107. ALS Limited Company Information Table 108. ALS Limited Business Overview Table 109. ALS Limited Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. ALS Limited Drug Detection and Analysis Product Portfolio Table 111. ALS Limited Recent Development Table 112. STERIS Company Information Table 113. STERIS Business Overview Table 114. STERIS Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. STERIS Drug Detection and Analysis Product Portfolio Table 116. STERIS Recent Development Table 117. LGC Limited Company Information Table 118. LGC Limited Business Overview Table 119. LGC Limited Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. LGC Limited Drug Detection and Analysis Product Portfolio Table 121. LGC Limited Recent Development Table 122. Almac Group Company Information Table 123. Almac Group Business Overview Table 124. Almac Group Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Almac Group Drug Detection and Analysis Product Portfolio Table 126. Almac Group Recent Development Table 127. Catalent Company Information Table 128. Catalent Business Overview Table 129. Catalent Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Catalent Drug Detection and Analysis Product Portfolio Table 131. Catalent Recent Development Table 132. Cambrex Company Information Table 133. Cambrex Business Overview Table 134. Cambrex Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Cambrex Drug Detection and Analysis Product Portfolio Table 136. Cambrex Recent Development Table 137. Alcami Company Information Table 138. Alcami Business Overview Table 139. Alcami Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Alcami Drug Detection and Analysis Product Portfolio Table 141. Alcami Recent Development Table 142. Toxikon Company Information Table 143. Toxikon Business Overview Table 144. Toxikon Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Toxikon Drug Detection and Analysis Product Portfolio Table 146. Toxikon Recent Development Table 147. Boston Analytical Company Information Table 148. Boston Analytical Business Overview Table 149. Boston Analytical Drug Detection and Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Boston Analytical Drug Detection and Analysis Product Portfolio Table 151. Boston Analytical Recent Development Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Drug Detection and Analysis Product Image Figure 2. Global Drug Detection and Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Detection and Analysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chemical Drug Testing Image Figure 8. Biopharmaceutical Testing Image Figure 9. Traditional Chinese Medicine Testing Image Figure 10. Others Image Figure 11. Global Drug Detection and Analysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Drug Detection and Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Drug Detection and Analysis Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Companies Image Figure 15. Biopharmaceutical Companies Image Figure 16. Drug Regulatory Authorities Image Figure 17. Others Image Figure 18. Global Drug Detection and Analysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Detection and Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Detection and Analysis Sales Value Share by Application (2021-2032) Figure 21. Global Drug Detection and Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Drug Detection and Analysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Drug Detection and Analysis Sales Value (2021-2032) & (US$ Million) Figure 24. North America Drug Detection and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Drug Detection and Analysis Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Drug Detection and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Drug Detection and Analysis Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Drug Detection and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Drug Detection and Analysis Sales Value (2021-2032) & (US$ Million) Figure 30. South America Drug Detection and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Drug Detection and Analysis Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Drug Detection and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Drug Detection and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Drug Testing
  • Biopharmaceutical Testing
  • Traditional Chinese Medicine Testing
  • Others
Applications
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Drug Regulatory Authorities
  • Others
Companies covered
  • Eurofins Scientific
  • SGS
  • Labcorp
  • Intertek
  • WuXi AppTec
  • Charles River Laboratories
  • ICON pIc
  • IQVIA
  • Medpace
  • Syneos Health
  • Frontage Laboratories
  • Pace Analytical Services
  • Element Materials Technology
  • ALS Limited
  • STERIS
  • LGC Limited
  • Almac Group
  • Catalent
  • Cambrex
  • Alcami
  • Toxikon
  • Boston Analytical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Detection and Analysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Detection and Analysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Detection and Analysis Market Dynamics
  1. 2.1 Drug Detection and Analysis Industry Trends
  2. 2.2 Drug Detection and Analysis Industry Drivers
  3. 2.3 Drug Detection and Analysis Industry Opportunities and Challenges
  4. 2.4 Drug Detection and Analysis Industry Restraints
3 Drug Detection and Analysis Market by Company
  1. 3.1 Global Drug Detection and Analysis Company Revenue Ranking in 2025
  2. 3.2 Global Drug Detection and Analysis Revenue by Company (2021-2026)
  3. 3.3 Global Drug Detection and Analysis Company Ranking (2024-2026)
  4. 3.4 Global Drug Detection and Analysis Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Detection and Analysis Company Product Type and Application
  6. 3.6 Global Drug Detection and Analysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Detection and Analysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Detection and Analysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Detection and Analysis Market by Type
  1. 4.1 Drug Detection and Analysis Type Introduction
  2. 4.1.1 Chemical Drug Testing
  3. 4.1.2 Biopharmaceutical Testing
  4. 4.1.3 Traditional Chinese Medicine Testing
  5. 4.1.4 Others
  6. 4.2 Global Drug Detection and Analysis Sales Value by Type
  7. 4.2.1 Global Drug Detection and Analysis Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drug Detection and Analysis Sales Value by Type (2021-2032)
  9. 4.2.3 Global Drug Detection and Analysis Sales Value Share by Type (2021-2032)
5 Drug Detection and Analysis Market by Application
  1. 5.1 Drug Detection and Analysis Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Biopharmaceutical Companies
  4. 5.1.3 Drug Regulatory Authorities
  5. 5.1.4 Others
  6. 5.2 Global Drug Detection and Analysis Sales Value by Application
  7. 5.2.1 Global Drug Detection and Analysis Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug Detection and Analysis Sales Value by Application (2021-2032)
  9. 5.2.3 Global Drug Detection and Analysis Sales Value Share by Application (2021-2032)
6 Drug Detection and Analysis Regional Value Analysis
  1. 6.1 Global Drug Detection and Analysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Detection and Analysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Detection and Analysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Detection and Analysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Detection and Analysis Sales Value (2021-2032)
  7. 6.3.2 North America Drug Detection and Analysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Detection and Analysis Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Detection and Analysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Detection and Analysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Detection and Analysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Detection and Analysis Sales Value (2021-2032)
  16. 6.6.2 South America Drug Detection and Analysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Detection and Analysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Detection and Analysis Sales Value Share by Country, 2025 VS 2032
7 Drug Detection and Analysis Country-level Value Analysis
  1. 7.1 Global Drug Detection and Analysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Detection and Analysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Detection and Analysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Detection and Analysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Detection and Analysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Detection and Analysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Detection and Analysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Drug Detection and Analysis Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 SGS
  8. 8.2.1 SGS Company Information
  9. 8.2.2 SGS Business Overview
  10. 8.2.3 SGS Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SGS Drug Detection and Analysis Product Portfolio
  12. 8.2.5 SGS Recent Developments
  13. 8.3 Labcorp
  14. 8.3.1 Labcorp Company Information
  15. 8.3.2 Labcorp Business Overview
  16. 8.3.3 Labcorp Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Labcorp Drug Detection and Analysis Product Portfolio
  18. 8.3.5 Labcorp Recent Developments
  19. 8.4 Intertek
  20. 8.4.1 Intertek Company Information
  21. 8.4.2 Intertek Business Overview
  22. 8.4.3 Intertek Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Intertek Drug Detection and Analysis Product Portfolio
  24. 8.4.5 Intertek Recent Developments
  25. 8.5 WuXi AppTec
  26. 8.5.1 WuXi AppTec Company Information
  27. 8.5.2 WuXi AppTec Business Overview
  28. 8.5.3 WuXi AppTec Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi AppTec Drug Detection and Analysis Product Portfolio
  30. 8.5.5 WuXi AppTec Recent Developments
  31. 8.6 Charles River Laboratories
  32. 8.6.1 Charles River Laboratories Company Information
  33. 8.6.2 Charles River Laboratories Business Overview
  34. 8.6.3 Charles River Laboratories Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Charles River Laboratories Drug Detection and Analysis Product Portfolio
  36. 8.6.5 Charles River Laboratories Recent Developments
  37. 8.7 ICON pIc
  38. 8.7.1 ICON pIc Company Information
  39. 8.7.2 ICON pIc Business Overview
  40. 8.7.3 ICON pIc Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ICON pIc Drug Detection and Analysis Product Portfolio
  42. 8.7.5 ICON pIc Recent Developments
  43. 8.8 IQVIA
  44. 8.8.1 IQVIA Company Information
  45. 8.8.2 IQVIA Business Overview
  46. 8.8.3 IQVIA Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 IQVIA Drug Detection and Analysis Product Portfolio
  48. 8.8.5 IQVIA Recent Developments
  49. 8.9 Medpace
  50. 8.9.1 Medpace Company Information
  51. 8.9.2 Medpace Business Overview
  52. 8.9.3 Medpace Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medpace Drug Detection and Analysis Product Portfolio
  54. 8.9.5 Medpace Recent Developments
  55. 8.10 Syneos Health
  56. 8.10.1 Syneos Health Company Information
  57. 8.10.2 Syneos Health Business Overview
  58. 8.10.3 Syneos Health Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Syneos Health Drug Detection and Analysis Product Portfolio
  60. 8.10.5 Syneos Health Recent Developments
  61. 8.11 Frontage Laboratories
  62. 8.11.1 Frontage Laboratories Company Information
  63. 8.11.2 Frontage Laboratories Business Overview
  64. 8.11.3 Frontage Laboratories Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Frontage Laboratories Drug Detection and Analysis Product Portfolio
  66. 8.11.5 Frontage Laboratories Recent Developments
  67. 8.12 Pace Analytical Services
  68. 8.12.1 Pace Analytical Services Company Information
  69. 8.12.2 Pace Analytical Services Business Overview
  70. 8.12.3 Pace Analytical Services Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pace Analytical Services Drug Detection and Analysis Product Portfolio
  72. 8.12.5 Pace Analytical Services Recent Developments
  73. 8.13 Element Materials Technology
  74. 8.13.1 Element Materials Technology Company Information
  75. 8.13.2 Element Materials Technology Business Overview
  76. 8.13.3 Element Materials Technology Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Element Materials Technology Drug Detection and Analysis Product Portfolio
  78. 8.13.5 Element Materials Technology Recent Developments
  79. 8.14 ALS Limited
  80. 8.14.1 ALS Limited Company Information
  81. 8.14.2 ALS Limited Business Overview
  82. 8.14.3 ALS Limited Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ALS Limited Drug Detection and Analysis Product Portfolio
  84. 8.14.5 ALS Limited Recent Developments
  85. 8.15 STERIS
  86. 8.15.1 STERIS Company Information
  87. 8.15.2 STERIS Business Overview
  88. 8.15.3 STERIS Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  89. 8.15.4 STERIS Drug Detection and Analysis Product Portfolio
  90. 8.15.5 STERIS Recent Developments
  91. 8.16 LGC Limited
  92. 8.16.1 LGC Limited Company Information
  93. 8.16.2 LGC Limited Business Overview
  94. 8.16.3 LGC Limited Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  95. 8.16.4 LGC Limited Drug Detection and Analysis Product Portfolio
  96. 8.16.5 LGC Limited Recent Developments
  97. 8.17 Almac Group
  98. 8.17.1 Almac Group Company Information
  99. 8.17.2 Almac Group Business Overview
  100. 8.17.3 Almac Group Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Almac Group Drug Detection and Analysis Product Portfolio
  102. 8.17.5 Almac Group Recent Developments
  103. 8.18 Catalent
  104. 8.18.1 Catalent Company Information
  105. 8.18.2 Catalent Business Overview
  106. 8.18.3 Catalent Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Catalent Drug Detection and Analysis Product Portfolio
  108. 8.18.5 Catalent Recent Developments
  109. 8.19 Cambrex
  110. 8.19.1 Cambrex Company Information
  111. 8.19.2 Cambrex Business Overview
  112. 8.19.3 Cambrex Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cambrex Drug Detection and Analysis Product Portfolio
  114. 8.19.5 Cambrex Recent Developments
  115. 8.20 Alcami
  116. 8.20.1 Alcami Company Information
  117. 8.20.2 Alcami Business Overview
  118. 8.20.3 Alcami Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Alcami Drug Detection and Analysis Product Portfolio
  120. 8.20.5 Alcami Recent Developments
  121. 8.21 Toxikon
  122. 8.21.1 Toxikon Company Information
  123. 8.21.2 Toxikon Business Overview
  124. 8.21.3 Toxikon Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Toxikon Drug Detection and Analysis Product Portfolio
  126. 8.21.5 Toxikon Recent Developments
  127. 8.22 Boston Analytical
  128. 8.22.1 Boston Analytical Company Information
  129. 8.22.2 Boston Analytical Business Overview
  130. 8.22.3 Boston Analytical Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Boston Analytical Drug Detection and Analysis Product Portfolio
  132. 8.22.5 Boston Analytical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst